Cargando…
Efficacy and side effects of immune checkpoint inhibitors in the treatment of colorectal cancer
Colorectal cancers (CRCs) remain one of the most common and challenging neoplasia in the Western world. The response rate of immunotherapeutic treatment approaches in a subset of advanced CRCs is remarkable and has sustainably changed treatment regimens. Unfortunately, currently available immunother...
Autores principales: | Manz, Salomon M., Losa, Marco, Fritsch, Ralph, Scharl, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053828/ https://www.ncbi.nlm.nih.gov/pubmed/33948110 http://dx.doi.org/10.1177/17562848211002018 |
Ejemplares similares
-
Endocrine side effects of immune checkpoint inhibitors
por: Cardona, Zulma, et al.
Publicado: (2023) -
Editorial: Immune checkpoint inhibitors in cancer: balancing the benefits with the side effects?
por: Gomes-Lima, Cristiane J., et al.
Publicado: (2023) -
Myasthenia Gravis as an Immune-Mediated Side Effect of Checkpoint Inhibitors
por: Heleno, Caio T, et al.
Publicado: (2021) -
The side effects of immune checkpoint inhibitor therapy on the endocrine system
por: Goyal, Itivrita, et al.
Publicado: (2021) -
Predictive molecular markers for the treatment with immune checkpoint inhibitors in colorectal cancer
por: Du, Fenqi, et al.
Publicado: (2021)